Professor Peter Hersey

Peter Hersey is an honorary Professor of Immuno Oncology in the University
of Sydney and a faculty member of the Melanoma Institute Australia. He has
conducted a number of phase I to III trials of immunotherapy in melanoma,
including use of modified peptide antigens and dendritic cell vaccines. He
has taken a leading role in studies investigating properties of melanoma
cells that make them resistant to treatment and new treatment approaches
to overcome these properties. He is generally recognized as a pioneer of
immunotherapy for melanoma in Australia, and has participated in most of
the key clinical trials on immunotherapy with immune checkpoint inhibitors.
He continues translational research on melanoma in the Centenary Institute
as joint holder of a NHMRC program grant on melanoma.

« Back